跳至主要内容
临床试验/NCT04429282
NCT04429282Unknown3 期

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.

Yi Feng, MD1 个研究点 分布在 1 个国家目标入组 396 人开始时间: 2020年6月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
396
试验地点
1
主要终点
the amount of morphine administered

研究概览

简要总结

This study was to evaluate the efficacy and safety of intravenously administered ibuprofen 400mg and 800 mg q6h for the management of moderate to severe postoperative pain in Chinese population.

详细描述

This randomized, parallel, double-blind, placebo controlled multi-center clinical study was conducted in 396 patients scheduled to undergo elective general anesthesia laparotomy or orthopedic surgery. Patients were randomly divided into three groups in radio 1:1:1 received respectively IV placebo, ibuprofen 400 mg or ibuprofen 800 mg. The first dose of study drugs was administered intravenously at the time of wound closure and then every 6 hours within 48 hours after the operation. At the end of surgical suture, 5mg morphine was injected intravenously, and then the patient-controlled intravenous analgesia pump was connected. Efficacy was assessed by morphine dosage during the first 24 hours, pain intensity score, and area under the pain-time curve after surgery. Safety was assessed by the incidence of adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Enrollment was open to patients undergoing scheduled abdominal surgery (intestinal or lower abdomen) or orthopedic surgery (such as knee arthroplasty or shoulder joint reconstruction) under general anesthesia with endotracheal intubation and were expected to require patient-controlled intravenous analgesia (PCIA) pump for more than 24h for moderate to severe pain after surgery.

排除标准

  • Those who can not understand the NRS score and cooperate with the evaluation; those who had head trauma or complicated with organic lesions of the central nervous system within 4 weeks before operation; those who developed coagulation dysfunction or took anticoagulants and antiplatelet drugs; those with a history of severe cardio-cerebrovascular disease, heart failure; those with liver and kidney dysfunction, severe endocrine system diseases, mental illness; those with a history of peptic ulcer or bleeding; those who did not control grade 2 or above hypertension or were still taking two or more of antihypertensive drugs such as angiotensin converting enzyme inhibitors (ACEI), angiotensin converting enzyme antagonists (ARB) and diuretics at admission; Increased toxicity due to the interaction of methotrexate, lithium preparations, etc. with the test drug; use of NSAIDs or analgesic muscle relaxants within 24 hours before operation, narcotic dependence or tolerance; allergy to ibuprofen or other NSAIDs; pregnant or lactating women

研究组 & 干预措施

ibuprofen( 400mg group)

Experimental

Patients were randomly divided into the group received respectively IV ibuprofen 400 mg .

干预措施: ibuprofen (Drug)

ibuprofen( 800mg group)

Experimental

Patients were randomly divided into the group received respectively IV ibuprofen 800 mg.

干预措施: ibuprofen (Drug)

placebo group

Placebo Comparator

Patients were randomly divided into the group received respectively IV placebo,.

干预措施: Placebo (Drug)

结局指标

主要结局

the amount of morphine administered

时间窗: during the first 24 hours

after surgery.

次要结局

  • Total frequency and effective frequency of PCA(within 24 hours)
  • Pain intensity (PI)(at 0 hour,1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 18 hours, 24 hours, 30 hours, 36 hours, 42 hours and 48 hours immediately after the first administration.)
  • Treatment failure rate(within 24 hours after the operation)
  • The area under the PI-time curve (AUC)(across 3 time periods (1-24 hours, 6-24 hours, 12-24 hours))
  • Patients' evaluation of the study drug(after 48 hours of medication)

研究者

发起方
Yi Feng, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yi Feng, MD

Director of department of anesthesiology and painmanagement

Peking University People's Hospital

研究点 (1)

Loading locations...

相似试验